Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Idaho for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Idaho only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Idaho (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Andrew Kominsky (NPI 1265478697)

Field	Value
Entity Type	Individual
Organization	Andrew Kominsky
Address	3815 N Schreiber Way Unit 101
City	Coeur D Alene
State	ID
ZIP	83815
Taxonomy	Medical Oncology Physician
NPI Enumerated	June 22, 2006

Payer Source	Total Paid
Medicare	$339.1K
Medicaid	$0

Key Findings

This provider’s public billing footprint is narrowly Medicare-centric: total Medicare revenue is $339.1K and there is no Medicaid billing on file, so operational and revenue exposure is effectively single-payer Medicare rather than a mixed Medicaid/Medicare practice. That concentration means changes in Medicare reimbursement or utilization would materially affect the practice’s topline.

Revenue is heavily concentrated in a very small set of codes: the precomputed top-3 Medicare codes account for 81.1% of total Medicare revenue, with J9271 representing 56.5%, J0897 representing 17.5%, and 99213 representing 7.1% of Medicare revenue. This level of concentration indicates the practice derives the bulk of its Medicare dollars from high-cost oncology drug administration plus routine outpatient evaluation visits.

The code mix and descriptions identify a medical oncology infusion practice focused on immunotherapy and bone-targeted therapy: J9271 (pembrolizumab) is the single largest line-item revenue driver and J0897 (denosumab) is the second-largest, while chemotherapy administration codes such as 96413 appear in the top 10. The presence of M0010 (EOM monthly enhanced oncology services) and multiple infusion/administration codes supports that the practice bills for both drug administration and oncology care management services.

Despite J9271 being the largest revenue source, the provider is not a national volume leader for that drug: J9271 ranks #1719 of 1841 providers nationally (6th percentile) and is described as having "typical, unremarkable volume for this code." In other words, pembrolizumab drives revenue centrally for this provider but the provider’s pembrolizumab volume is low relative to the full national peer set.

J0897 (denosumab) is the second-largest revenue source and shows a middle-of-the-pack national standing: it ranks #4402 of 10057 providers nationally (56th percentile) and is labeled "typical, unremarkable volume for this code," indicating ordinary denosumab utilization compared with national peers rather than a specialty niche.

Office/outpatient evaluation-and-management activity contributes a meaningful but smaller share of revenue: 99213 accounts for $24.2K (7.1% of Medicare revenue) and is recorded at the 90th percentile nationally (rank #43664 of 457151) while still described as "typical, unremarkable volume for this code." This suggests a steady outpatient follow-up panel that complements infusion work rather than replacing it.

Practice tenure is long-standing: the NPI was enumerated on 2006-06-22 (~20 years ago), indicating the provider has an established billing history and likely entrenched referral or care pathways in the local market. That longevity may support stable patient volume even though the Medicare revenue base shown here is modest in absolute dollar terms.

Ancillary services and diagnostics (CT scans, lab panels, venous access services) appear only as small contributors to Medicare revenue, typically each under a few percent of total revenue. Examples include 74177 and 71260 imaging entries and lab CPTs such as 85025 and 80053; these low-dollar items imply the practice relies primarily on high-cost drug administration rather than ancillary testing for Medicare revenue diversification.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

28 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	4,800	$40	$192K
J0897	Injection, denosumab, 1 mg	3,120	$20	$59.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	370	$70	$24.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	120	$100	$11.8K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	110	$100	$11.4K
74177	The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs.	30	$210	$6.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	50	$110	$5.4K
M0010	Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services	60	$70	$4.5K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	30	$170	$4.5K
J0185	Injection, aprepitant, 1 mg	3,510	$1	$3.5K

Showing 1–10 of 28

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 28 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Idaho Distribution

Andrew Kominsky — 0 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Idaho

Full comparison — all codes billed, vs. state median

28 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	3	10	12,400	$40	$469.8K
J0897	10	30	2,580	$20	$76.2K
96413	10	20	250	$90	$26K
74177	113	130	120	$70	$10.6K
99214	1,059	2,690	90	$70	$10.4K
M0010	2	10	120	$70	$8.7K
96365	16	20	80	$40	$7.4K
96417	5	10	70	$50	$6.7K
J0185	2	10	4,750	$1	$6.5K
99213	156	2,770	70	$50	$5.7K

Showing 1–10 of 28

Related Providers

Other providers that share a Tax Identification Number (TIN) with Andrew Kominsky, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Bartels	ID	Hematology & Oncology Physician	$3.5M	$0
Danko Martincic	ID	Hematology & Oncology Physician	$2.6M	$0
Howard Kenney	ID	Rheumatology Physician	$1.2M	$0
Dustin Dinning	ID	Rheumatology Physician	$1.1M	$0
Jonathan Sharrett	ID	Radiation Oncology Physician	$727.8K	$0
Carl Walker	WA	Urology Physician	$209.2K	$0
Ian Udell	MT	Urology Physician	$117.7K	$0
Stephanie Hart	ID	Nurse Practitioner	$10.3K	$0

Nearby Providers

Other providers in the same ZIP code as Andrew Kominsky, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Syringa Family Partnership, LLC	ID	Early Intervention Provider Agency	$0	$10.4M
North Star Child Development Center	ID	Clinic/Center	$0	$9.4M
Tesh, Inc.	ID	Developmentally Disabled Services Day Training Agency	$0	$3.5M
Jump Start Pediatric Therapy, LLC	ID	Physical Therapy Clinic/Center	$0	$3.3M
Synergy Healthcare For Kids Inc.	ID	Rehabilitation Clinic/Center	$0	$1.8M
George J Loftus Iii, Dds, LLC	ID	General Practice Dentistry	$0	$1.8M
A Compassionate In-home Care LLC	ID	In Home Supportive Care Agency	$0	$1.6M
Rathdrum Clinic, Inc.	ID	Addiction Medicine (Family Medicine) Physician	$0	$1.1M
Emeritus Corporation	ID	Assisted Living Facility	$0	$739.9K
Empowered Through Play LLC	ID	Mental Health Counselor	$0	$641K

Andrew Kominsky — Billing Profile & Reimbursement Data

Sign up for Andrew Kominsky — Billing Profile & Reimbursement Data policy alerts

Andrew Kominsky — Billing Profile & Reimbursement Data

Sign up for Andrew Kominsky — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References